Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial-Reference-Cited by-同舟云学术

Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial

Published:2023-06 Issue:6 Volume:18 Page:780-791
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Zhao Jun,Zhao Liang,Guo Wei,Wang Shuhang,Tao Xiuli,Li Lin,Mao Yousheng,Tan Fengwei,Gao Yushun,Wu Ning,Ying Jianming,Xue Qi,Li Ning,Gao Shugeng^ORCID,He Jie

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Optimising treatment for post-operative lung cancer recurrence;Subotic;Eur Respir J,2016

2. Recurrence after surgery in patients with NSCLC;Uramoto;Transl Lung Cancer Res,2014

3. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;Lancet,2014

4. Safety and efficacy of neoadjuvant immune checkpoint inhibitor therapy in patients with resectable non-small-cell lung cancer: a systematic review;Zhao;Target Oncol,2021

5. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint;Hellmann;Lancet Oncol,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review;International Immunopharmacology;2024-11

2. Clinical applications of circulating biomarkers in non-small cell lung cancer;Frontiers in Cell and Developmental Biology;2024-08-21

3. Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer;Journal for ImmunoTherapy of Cancer;2024-08

4. Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer;Future Oncology;2024-07-29

5. Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study;Clinical Lung Cancer;2024-07